Blog from IFPMA ADG Greg Perry following his visit to Cabo Verde
Find out here an insight that Greg Perry gives around WHO Afro Global Health Forum 2019
Read More
Thought Leader Series in Vaccines
A mustread from experts talking about the value of vaccines
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2022-07-19 12:00:30
Pharma proposes to work with G7 and G20 on a joint solution for better access to vaccines and treatments around the world for future pandemics
For future pandemics, we will build on the achievements which led to developing and scaling up multiple safe and effective ...
Read More2022-06-21 09:39:33
Global pharmaceutical industry leaders meet with German officials to discuss life sciences innovation in Germany and global pandemic response involving the G7
Berlin, 21 June, 2022 – Today, global leaders from the pharmaceutical industry met with German ...
Read More2022-06-17 07:12:58
Pharmaceutical industry expresses deep disappointment with decision on waiving intellectual property rights adopted at the World Trade Organization Ministerial Conference
IFPMA, the body representing biopharmaceutical companies in Geneva, expresses deep disappointment with the decision taken ...
Read More2022-05-23 08:17:57
Improving access to and use of essential life-saving cancer medicines in LLMICs
This news release was originally published by UICC on 20 May 2022. IFPMA and many ...
Read More2022-05-22 23:00:57
Pharma analysis of lessons learned from COVID-19 pandemic informs and offers shared solutions to consolidate innovation successes and improve equitable access for future pandemic response
Swift pathogen surveillance and sharing, an enabling innovation ecosystem, and regulatory agility are among the ...
Read More2022-04-26 17:00:48
Celebrating World IP Day with a focus on youth and innovation
Geneva, 26 April 2022 – On World Intellectual Property (IP) Day, the International Federation of ...
Read More2022-04-13 12:45:21
COVID-19 vaccines and treatments output continues apace; as health systems and last mile hurdles remain collective stumbling blocks
To date, over 13 billion doses of COVID-19 vaccines have been produced and 11 billion ...
Read More
Latest Statement
2022-09-28 17:00:54
IFPMA statement at the 74th session of the WHO Regional Committee for the Americas on the COVID-19 pandemic in the region of the Americas
28 September 2022, Washington, DC, USA — IFPMA welcomes the opportunity to share our from Covid-19 Lessons Learned, which highlights ...
Read More2022-09-28 15:00:25
IFPMA Statement at the WHO Second Public Hearings to support the intergovernmental negotiating body to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention, preparedness and response
To date, over 13 billion doses of COVID-19 vaccines have ...
Read More2022-09-13 11:00:07
IFPMA and GSCF statement at the 72nd session of the WHO Regional Committee for Europe on Strengthening health emergency preparedness, response, and resilience: learning the lessons and building back better
To date, over 13 billion doses of COVID-19 vaccines have ...
Read More2022-09-13 10:00:34
R&D based biopharmaceutical industry statement in support of the Seventh Global Fund Replenishment
To date, over 13 billion doses of COVID-19 vaccines have ...
Read More2022-09-07 11:32:38
IFPMA statement at the 75th session of the WHO Regional Committee for South-East Asia on Monitoring progress and acceleration plan for NCDs
To date, over 13 billion doses of COVID-19 vaccines have ...
Read More2022-08-24 15:15:20
IFPMA statement at the 72nd session of the WHO Regional Committee for Africa: Regional strategy for health security and emergencies 2022-2030
To date, over 13 billion doses of COVID-19 vaccines have ...
Read More2022-07-19 14:09:04
IFPMA written statement for the second meeting of the intergovernmental negotiating body to draft and negotiate a WHO convention, agreement or other international instrument on pandemic prevention preparedness and response
To date, over 13 billion doses of COVID-19 vaccines have ...
Read More
mailto:a.jones@ifpma.org
Abigail Jones - Director, Communications
Abigail Jones is responsible for communications at IFPMA. She joined IFPMA after over 25 years in international communications and public affairs consultancy, where she worked for many blue-chip companies, trade associations, think tanks, coalition and advocacy groups. Abigail supported the launches and ongoing work of the Fight the Fakes campaign, AMR Industry Alliance and Pat-INFORMED.
mailto:m.depol@ifpma.org
Twitter @MorganePol
Morgane De Pol - Deputy Director, Communications
Morgane develops and implements public affairs programs that build trust, dialogue and collaboration between the innovative biopharmaceutical industry and other global players in the health community. Morgane has international experience in developing and rolling-out integrated advocacy and communications strategies in the global health sector, with specific focus on institutional communications, media relations, alliance building and event management.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
News Release
Meeting discusses COVID-19 vaccine manufacturing bottlenecks that must be urgently tackled for C19 vaccine output to reach its full potential
9 March 2021: Chatham House, in collaboration with COVAX, IFPMA, DVCMN, and BIO, convened a Global COVID-19 Vaccine Supply Chain & Manufacturing Summit on 8th and 9th March. The unprecedented scaling up of vaccine manufacturing, from zero to billions of
Read MoreOur Blog
Innovative partnership model to improve access to cancer care in LMICs
This blog was originally published on Health Awareness on 3 October 2022. Through public and private sector partnerships, a global initiative innovates for better access to cancer care worldwide. The global prevalence of cancer is increasing rapidly, presenting an especially heavy burden for people in low and middle-income countries (LMICs). Collaborative and innovative thinking is now needed to expand access to quality cancer care. In...
Read More
The biopharmaceutical industry continues to innovate and push science forward to manage the COVID-19 pandemic and be better prepared for future global health threats
Viruses don’t stand still. And neither do we. It’s been almost two years since the administration of the first COVID-19 vaccine in December 2020 and as of September 2022, more than two thirds of people worldwide had received at least one COVID-19 vaccine dose. The biopharmaceutical industry is proud to continue to play a key role in helping to manage the worst global health pandemic...
Read More
A collective approach can improve access to quality cancer care
This article was originally published by Re:solve Global Health on 14 July 2022. The task of taking quality care to those living with cancer grows more difficult with the exploding number of new cases. A new initiative pools together expertise to widen access to timely and effective treatment. The global cancer population is significant and expanding. From over 19 million a year in 2020, the...
Read MoreLatest Tweets
